Coronary Disease in Women

• I. Introduction.- 1 The Institute of Medicine Report, Women’s Cardiovascular Health, and Evidence-Based Medicine.- 2 Evidence-Based Medicine in the Assessment of Women at Risk for Cardiovascular Disease.- II. Screening and Diagnosis of Coronary Disease in Women.- A. Cardiovascular Epidemiology in Women.- 3 Population-Based Sex Differences in Disease Incidence and Prevalence.- 4 Risk Detection and Primary Prevention in Women.- 5 Early Detection of Coronary Artery Disease in Women: Role of Coronary Artery Calcium Scanning With EBT.- 6 Heart Failure in Women: Epidemiology, Gender Differences in Pathophysiology, and Implications for Therapy.- 7 Diastolic Dysfunction in Women.- 8 Functional Capacity and Activities of Daily Living in Women.- 9 Special Considerations for Minority Women.- B. Varying Symptom Presentation in Women.- 10 Clinical Risk Assessment in Women: Chest Discomfort. Report from the WISE Study.- 11 Quality-of-Life Issues for Women With Coronary Disease.- C. Choosing the Best Diagnostic Test for Women.- 12 Should All Women With Suspected Coronary Disease Undergo Stress Cardiac Imaging?.- 13 State-of-the-Art Diagnostic Testing in Women: A Research Update.- III. Management of Coronary Disease in Women.- A. Evaluation of Stable Chest Pain Syndromes in Women.- 14 Treatment Strategies for Women With Stable Angina.- 15 Improving the Diagnosis and Management of Women With Coronary Disease in Primary Care Settings.- B. Evaluation of Acute Ischemic Syndromes in Women.- 16 Evaluation of Acute Chest Pain in Women.- 17 Acute Ischemic Syndromes: Differences in Presentation and Treatment in Women.- C. Variations in Therapeutic Effectiveness in Women.- 18 Effectiveness of Coronary Revascularization: Gender and Racial Differences.- 19 Electrophysiology: TreatmentConsiderations in Women.- 20 Exercise Training and Cardiac Rehabilitation for Women.- 21 Menopausal Hormone Therapy: Is There Evidence for Cardiac Protection?.- IV. Economics and Policy Issues in Health Care Related to Women.- 22 Gender Bias: Is It Real and How Does It Affect Diagnosis, Management, and Outcome?.- 23 The Role of Women’s Health Centers in Improving Access and Process of Care.- 24 Obstetrician/Gynecologists, Primary Care, and Cardiovascular Disease.- 25 Health Technology Assessment in the Era of Managed Care: Issues in Women’s Health Care.- 26 Issues in the Analysis of Cost-Effectiveness in the Diagnosis and Treatment of Coronary Artery Disease in Women.

"...contemporary and up-to-date review of women and coronary artery disease." - Texas Heart Institute Journal "The book provides a good overview of the various ways in which women with known or suspected CAD differ from men, whether from the epidemiologic, clinical, or management perspective. This text will provide a wake-up call for clinicians who are not sufficiently sensitive to the potentially pernicious and corrosive effects of gender bias in the management of CAD in women." - Annals of Internal Medicine "There is much to be learned from this book..." -New England Journal of Medicine "Comprehensive and highly practical...offers both basic and clinical scientists an up-to-date collection of cutting edge protocols for solving he widest variety of novel flow cytometry problems." - Clin Lab "All methods are described in detail, and this book has the potential to become the geneticist's and biochemist's 'cook book' to study recombination in eukaryotes. It provides both experts and novices that want to move into the field of recombination with an accessible handbook...it provides trouble-shooting guides and the principles behind techniques as well as describing the basics of recombination." - ChemBioChem "...excellent book on all aspects of coronary artery disease (CAD) in women." - Doody's Health Sciences Book Review Journal